(COG ACNS1022) A Phase II Randomized Trial of Lenalidomide (NSC #703813, IND #70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
Description: 

To determine the objective response rate of children with recurrent, refractory or progressive juvenile pilocytic astrocytomas and optic pathway gliomas who are treated with Regimen A low-dose or Regimen B high-dose.

Study Number: 

NCG 217012

Phase: 
II
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01553149

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.